Dr. Marianne Klemp MD, PhD, works as a research director at Norwegian Knowledge Centre for the Health Services (NOKC) with a special emphasis on HTA of pharmaceuticals and health economic evaluations of all technologies. She has long experience from clinical research within cancer immunology and her special research focus has been to develop cancer vaccines. She has also wide experience from regulatory authorities with evaluation of new drugs, where she was active in the Gene Therapy Working Party at the European Medicines Agency (EMA). Her current research activities are concentrated around the use of HTA in decision-making along the life-cycle perspective of technologies. Klemp is also Associate Professor at the University of Oslo in Pharmacotherapy and she was originally trained as a surgeon.

HTA of pharmaceuticals and health economic evaluations of all technologies, cancer immunology and her special research focus has been to develop cancer vaccines, regulatory authorities with evaluation of new drugs.